SlideShare a Scribd company logo
Ebola virus 
disease (EVD) 
outbreak in 
western Africa 
Zsuzsanna Jakab 
WHO Regional Director for Europé 
5 November 2014, Brussels, Belgium
Largest EVD outbreak ever 
As of 31 October 2014, countries had reported 13 567 cases, including 
4 951 deaths. 
• Outbreak began in Guinea in December 2013 
• Involved local transmission in Guinea, Liberia, and Sierra Leone but 
also Nigeria (20), Spain (1) and the United States of America (4) 
• 523 health care workers infected; 269 died 
• Medical evacuations to France, Germany, Netherlands, Norway, 
Spain, the United Kingdom and the United States
Why this outbreak is different 
• First outbreak with movements of large groups of people, affecting 
big cities and multiple countries at once 
• Countries’ coping capacity has not been adequate to face such a large 
outbreak 
• Affected countries have weak health systems, lacking infrastructure 
and human resources 
• The response efforts must go beyond medical needs and address 
social, economic, development, logistic and security challenges
Senegal (17 October) and Nigeria (20 October): 
Ebola free
Public health strategies for control 
• Diagnosis: testing in WHO reference laboratories 
– Handling specimens requires highest biosecurity level (BSL 4) 
• Case management 
– Strict infection prevention and control (IPC) measures required 
(patient isolation, personal protective equipment (PPE), etc.) and 
clinical management 
• Interrupt transmission chains: contact tracing and 21-day follow-up 
• Community participation to change risky behaviour and support the 
public health response
International Health Regulations 
(IHR 2005) 
• Emergency committee meetings: 6–7 August, 22 September and 22 
October 2014 
• 8 August 2014: Ebola outbreak in western Africa declared a public 
health emergency of international concern by WHO Director‐General 
• WHO recommendations to: 
– states with Ebola transmission 
– states with a potential or confirmed Ebola case, and unaffected states 
with land borders with affected states 
– all states
WHO recommendations to all states 
• No general ban on international travel or trade 
• States should be prepared to detect, investigate, and manage Ebola 
cases 
• Exit screening recommended 
• No postponements of mass gatherings or banning of participants from 
affected countries 
• States should be prepared to facilitate the evacuation and repatriation 
of their nationals who have been exposed to Ebola 
• States should provide travelers to Ebola-affected and at-risk areas, and 
the general public with relevant information
Beyond a public health emergency 
United Nations Mission for Ebola Emergency Response 
(UNMEER) 
• 18 September 2014: Security Council Resolution 2177 
• First‐ever UN emergency health mission; headquarters in Accra, Ghana 
• Objective: work with others to stop the Ebola outbreak 
• Strategic guidance: Secretary‐General's Special Envoy, David Nabarro 
• Operational direction: Secretary‐General's Special Representative, Anthony 
Banbury 
• Overall health strategy: WHO 
• Other UN agencies will act in their areas of expertise
Vaccine and treatment 
development 
• 2 potential vaccines in pre-clinical trials and 
5 candidate vaccines under initial consideration 
• Extraordinary fast-track procedures coordinated by 
WHO 
• Clinical trials expected to start by January 2015 
• Scale-up of vaccine stocks by June 2015 latest 
• Several potential treatments considered, including 
blood products from survivors
The risk to Europe 
• The risk of Ebola spreading in Europe is very low. 
• Sporadic imported cases in Europe and accidental 
contamination remain possible. 
• European countries have robust health systems 
and are well prepared to respond to Ebola. 
• There is low risk tolerance in Europe.
Elements of strong health systems 
• Strong surveillance systems 
• Laboratory capacity 
• Case management 
• Well equipped hospitals with isolation wards 
• Trained doctors and nurses 
• Strict adherence to IPC measures 
• Arrangements for tracing and following contacts 
• Risk communication
Ebola and international travel 
• WHO recommends exit screening in affected 
countries of departing travelers 
• Countries that decide to do entry screening need 
to ensure it does not interfere with travel and 
trade, and should share experience. 
• The main issue is to provide travelers with good 
information.
Medical evacuation 
“Countries should be prepared to facilitate the evacuation and repatriation 
of [their] nationals exposed to Ebola”. 
– IHR emergency committee 
• Medical evacuation ensures that international workers 
are available to help. 
• WHO coordinates medical evacuation for Ebola-infected 
international workers. 
• Treatment facilities are being established in western 
Africa for international responders.
WHO overall support in Europe 
• Early detection, risk assessment and investigation 
• Overall policy guidance 
• Support on capacity assessment and scaling up 
• Technical assistance on strengthening preparedness 
• Coordination with the European Union and UN 
• Support to global efforts (staff deployment and advocacy)
Real fight is not in Europe 
• The most effective way to prevent Ebola 
infections in Europe is to control the epidemic 
in western Africa. 
• This requires a fast and strong response. 
• The international community is scaling up its 
support. 
For further information, visit the WHO/Europe website 
(www.euro.who.int/en/ebola)

More Related Content

What's hot

NVBDCP 2019
NVBDCP 2019NVBDCP 2019
NVBDCP 2019
Mohini Jogdand
 
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
European Centre for Disease Prevention and Control
 
Roll Back Malaria (RBM)
Roll Back Malaria (RBM)Roll Back Malaria (RBM)
Roll Back Malaria (RBM)
cycyeastwood
 
NVBDCP
NVBDCPNVBDCP
NVBDCP National Vector Borne Disease Control Program
NVBDCP National Vector Borne Disease Control ProgramNVBDCP National Vector Borne Disease Control Program
NVBDCP National Vector Borne Disease Control Program
Mihir Rupani
 
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
jpndresearch
 
World Health Organisation. Fight against TB
World Health Organisation. Fight against TBWorld Health Organisation. Fight against TB
World Health Organisation. Fight against TB
StacyAntonova
 
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
MAHESWARI JAIKUMAR
 
NVBDCP
NVBDCPNVBDCP
Malaria in nepal
Malaria in nepalMalaria in nepal
Malaria in nepal
Anju sapkota
 
Who's Who in International Malaria Control
Who's Who in International Malaria Control Who's Who in International Malaria Control
Who's Who in International Malaria Control
stompoutmalaria
 
Lymphatic filariasis in nepal
Lymphatic filariasis in nepalLymphatic filariasis in nepal
Lymphatic filariasis in nepal
Anju sapkota
 
Humanitarian emergencies in the Eastern Mediterranean Region - English
Humanitarian emergencies in the Eastern Mediterranean Region - EnglishHumanitarian emergencies in the Eastern Mediterranean Region - English
Humanitarian emergencies in the Eastern Mediterranean Region - English
WHO Regional Office for the Eastern Mediterranean
 
Malarai seminar copy
Malarai seminar   copyMalarai seminar   copy
Malarai seminar copy
Shrestha Sabina
 
Malaria || Malaria in Nepal
Malaria || Malaria in NepalMalaria || Malaria in Nepal
Malaria || Malaria in Nepal
ShaileshPandeya
 
National vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin vermaNational vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin verma
Kartikesh Gupta
 
Control of diseases 3
Control of diseases 3Control of diseases 3
Control of diseases 3
Bruno Mmassy
 
National Vector Born Disease Control Programme:- Newer Concepts.
National Vector Born Disease Control Programme:- Newer Concepts.National Vector Born Disease Control Programme:- Newer Concepts.
National Vector Born Disease Control Programme:- Newer Concepts.
amol askar
 
Disease elimination.
Disease elimination.Disease elimination.
Disease elimination.
Mohith Mathew
 
Community Medicine: Filariasis in Nepal
Community Medicine: Filariasis in Nepal Community Medicine: Filariasis in Nepal
Community Medicine: Filariasis in Nepal
Adarsha Neupane
 

What's hot (20)

NVBDCP 2019
NVBDCP 2019NVBDCP 2019
NVBDCP 2019
 
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
 
Roll Back Malaria (RBM)
Roll Back Malaria (RBM)Roll Back Malaria (RBM)
Roll Back Malaria (RBM)
 
NVBDCP
NVBDCPNVBDCP
NVBDCP
 
NVBDCP National Vector Borne Disease Control Program
NVBDCP National Vector Borne Disease Control ProgramNVBDCP National Vector Borne Disease Control Program
NVBDCP National Vector Borne Disease Control Program
 
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
Philippe Amouyel - G7 Global Dementia Legacy Workshop, Tokyo, Nov 6th, 2014
 
World Health Organisation. Fight against TB
World Health Organisation. Fight against TBWorld Health Organisation. Fight against TB
World Health Organisation. Fight against TB
 
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
 
NVBDCP
NVBDCPNVBDCP
NVBDCP
 
Malaria in nepal
Malaria in nepalMalaria in nepal
Malaria in nepal
 
Who's Who in International Malaria Control
Who's Who in International Malaria Control Who's Who in International Malaria Control
Who's Who in International Malaria Control
 
Lymphatic filariasis in nepal
Lymphatic filariasis in nepalLymphatic filariasis in nepal
Lymphatic filariasis in nepal
 
Humanitarian emergencies in the Eastern Mediterranean Region - English
Humanitarian emergencies in the Eastern Mediterranean Region - EnglishHumanitarian emergencies in the Eastern Mediterranean Region - English
Humanitarian emergencies in the Eastern Mediterranean Region - English
 
Malarai seminar copy
Malarai seminar   copyMalarai seminar   copy
Malarai seminar copy
 
Malaria || Malaria in Nepal
Malaria || Malaria in NepalMalaria || Malaria in Nepal
Malaria || Malaria in Nepal
 
National vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin vermaNational vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin verma
 
Control of diseases 3
Control of diseases 3Control of diseases 3
Control of diseases 3
 
National Vector Born Disease Control Programme:- Newer Concepts.
National Vector Born Disease Control Programme:- Newer Concepts.National Vector Born Disease Control Programme:- Newer Concepts.
National Vector Born Disease Control Programme:- Newer Concepts.
 
Disease elimination.
Disease elimination.Disease elimination.
Disease elimination.
 
Community Medicine: Filariasis in Nepal
Community Medicine: Filariasis in Nepal Community Medicine: Filariasis in Nepal
Community Medicine: Filariasis in Nepal
 

Similar to Ebola virus disease (EVD) outbreak in western Africa

ebola-global response
ebola-global responseebola-global response
ebola-global response
Chitra Pai
 
Who theme final
Who theme finalWho theme final
Who theme final
mary jacob
 
International Health Regulation
International Health RegulationInternational Health Regulation
International Health Regulation
Sandeep Ghimire
 
national health programmes.pptx
national health programmes.pptxnational health programmes.pptx
national health programmes.pptx
Anush Nazar N
 
World Health Day 2014: Vector-borne diseases
World Health Day 2014: Vector-borne diseasesWorld Health Day 2014: Vector-borne diseases
World Health Day 2014: Vector-borne diseases
WHO Regional Office for Europe
 
Ebola SCHMT Slides.pptx
Ebola SCHMT Slides.pptxEbola SCHMT Slides.pptx
Ebola SCHMT Slides.pptx
MercyKendi3
 
Ebola-Awareness-presentation.pdf
Ebola-Awareness-presentation.pdfEbola-Awareness-presentation.pdf
Ebola-Awareness-presentation.pdf
DeriqueJoshua2
 
Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica
UWI_Markcomm
 
Dr. Tom Frieden, Update on the Ebola Criis
Dr. Tom Frieden, Update on the Ebola CriisDr. Tom Frieden, Update on the Ebola Criis
Dr. Tom Frieden, Update on the Ebola Criis
drenfeld
 
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINEINTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
Anujkumaranit
 
Stienstra Ebola lessons learned publiek 2015
Stienstra Ebola lessons learned publiek 2015Stienstra Ebola lessons learned publiek 2015
Stienstra Ebola lessons learned publiek 2015
Stef Stienstra
 
CDC Presentation, Los Angeles, CA - 11/7/14
CDC Presentation, Los Angeles, CA - 11/7/14CDC Presentation, Los Angeles, CA - 11/7/14
CDC Presentation, Los Angeles, CA - 11/7/14
drenfeld
 
HIV/AIDS in sudan
HIV/AIDS in sudanHIV/AIDS in sudan
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan NkeckGlobal response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
J-réné Nkeck
 
Communicable Diseases Discussion Paper.docx
Communicable Diseases Discussion Paper.docxCommunicable Diseases Discussion Paper.docx
Communicable Diseases Discussion Paper.docx
studywriters
 
Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014
Tim Inglis
 
disease eradication.pptx
disease eradication.pptxdisease eradication.pptx
disease eradication.pptx
NimrahFarooq4
 
World health organisation
World health organisationWorld health organisation
World health organisation
SumitaSharma16
 
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdfID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
AlanAzad1
 
Working for Europe: more equitable and sustainable
Working for Europe: more equitable and sustainableWorking for Europe: more equitable and sustainable
Working for Europe: more equitable and sustainable
WHO Regional Office for Europe
 

Similar to Ebola virus disease (EVD) outbreak in western Africa (20)

ebola-global response
ebola-global responseebola-global response
ebola-global response
 
Who theme final
Who theme finalWho theme final
Who theme final
 
International Health Regulation
International Health RegulationInternational Health Regulation
International Health Regulation
 
national health programmes.pptx
national health programmes.pptxnational health programmes.pptx
national health programmes.pptx
 
World Health Day 2014: Vector-borne diseases
World Health Day 2014: Vector-borne diseasesWorld Health Day 2014: Vector-borne diseases
World Health Day 2014: Vector-borne diseases
 
Ebola SCHMT Slides.pptx
Ebola SCHMT Slides.pptxEbola SCHMT Slides.pptx
Ebola SCHMT Slides.pptx
 
Ebola-Awareness-presentation.pdf
Ebola-Awareness-presentation.pdfEbola-Awareness-presentation.pdf
Ebola-Awareness-presentation.pdf
 
Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica
 
Dr. Tom Frieden, Update on the Ebola Criis
Dr. Tom Frieden, Update on the Ebola CriisDr. Tom Frieden, Update on the Ebola Criis
Dr. Tom Frieden, Update on the Ebola Criis
 
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINEINTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
INTERNATIONAL HEALTH AGENCIES/ COMMUNITY MEDICINE
 
Stienstra Ebola lessons learned publiek 2015
Stienstra Ebola lessons learned publiek 2015Stienstra Ebola lessons learned publiek 2015
Stienstra Ebola lessons learned publiek 2015
 
CDC Presentation, Los Angeles, CA - 11/7/14
CDC Presentation, Los Angeles, CA - 11/7/14CDC Presentation, Los Angeles, CA - 11/7/14
CDC Presentation, Los Angeles, CA - 11/7/14
 
HIV/AIDS in sudan
HIV/AIDS in sudanHIV/AIDS in sudan
HIV/AIDS in sudan
 
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan NkeckGlobal response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
 
Communicable Diseases Discussion Paper.docx
Communicable Diseases Discussion Paper.docxCommunicable Diseases Discussion Paper.docx
Communicable Diseases Discussion Paper.docx
 
Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014
 
disease eradication.pptx
disease eradication.pptxdisease eradication.pptx
disease eradication.pptx
 
World health organisation
World health organisationWorld health organisation
World health organisation
 
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdfID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
 
Working for Europe: more equitable and sustainable
Working for Europe: more equitable and sustainableWorking for Europe: more equitable and sustainable
Working for Europe: more equitable and sustainable
 

More from WHO Regional Office for Europe

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
WHO Regional Office for Europe
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
WHO Regional Office for Europe
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
WHO Regional Office for Europe
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
WHO Regional Office for Europe
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
WHO Regional Office for Europe
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
WHO Regional Office for Europe
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
WHO Regional Office for Europe
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
WHO Regional Office for Europe
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
WHO Regional Office for Europe
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
WHO Regional Office for Europe
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
WHO Regional Office for Europe
 

More from WHO Regional Office for Europe (20)

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Epidata 3/2022
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 1/2022
 
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Epidata 12/2021
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
Epidata 11/2021
 
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 10/2021
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 8/2021
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData 5/2021
 
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
 

Recently uploaded

chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Jokerwigs arts and craft
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
Pupayumnam1
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
geriatric changes in endocrine system.pdf
geriatric changes in endocrine system.pdfgeriatric changes in endocrine system.pdf
geriatric changes in endocrine system.pdf
Yes No
 
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa AjmanFriendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
Malayali Kerala Spa Ajman
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理
40fortunate
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
Vedanta A
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Jasper Colin
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdfnhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
Carolyn Harker
 
Get Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR TestGet Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR Test
NX Healthcare
 
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
5sj7jxf7
 
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptxCAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
Nursing Station
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Lighthouse Retreat
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 

Recently uploaded (20)

chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
geriatric changes in endocrine system.pdf
geriatric changes in endocrine system.pdfgeriatric changes in endocrine system.pdf
geriatric changes in endocrine system.pdf
 
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa AjmanFriendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdfnhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
 
Get Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR TestGet Covid Testing at Fit to Fly PCR Test
Get Covid Testing at Fit to Fly PCR Test
 
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
 
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptxCAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 

Ebola virus disease (EVD) outbreak in western Africa

  • 1. Ebola virus disease (EVD) outbreak in western Africa Zsuzsanna Jakab WHO Regional Director for Europé 5 November 2014, Brussels, Belgium
  • 2. Largest EVD outbreak ever As of 31 October 2014, countries had reported 13 567 cases, including 4 951 deaths. • Outbreak began in Guinea in December 2013 • Involved local transmission in Guinea, Liberia, and Sierra Leone but also Nigeria (20), Spain (1) and the United States of America (4) • 523 health care workers infected; 269 died • Medical evacuations to France, Germany, Netherlands, Norway, Spain, the United Kingdom and the United States
  • 3. Why this outbreak is different • First outbreak with movements of large groups of people, affecting big cities and multiple countries at once • Countries’ coping capacity has not been adequate to face such a large outbreak • Affected countries have weak health systems, lacking infrastructure and human resources • The response efforts must go beyond medical needs and address social, economic, development, logistic and security challenges
  • 4. Senegal (17 October) and Nigeria (20 October): Ebola free
  • 5. Public health strategies for control • Diagnosis: testing in WHO reference laboratories – Handling specimens requires highest biosecurity level (BSL 4) • Case management – Strict infection prevention and control (IPC) measures required (patient isolation, personal protective equipment (PPE), etc.) and clinical management • Interrupt transmission chains: contact tracing and 21-day follow-up • Community participation to change risky behaviour and support the public health response
  • 6. International Health Regulations (IHR 2005) • Emergency committee meetings: 6–7 August, 22 September and 22 October 2014 • 8 August 2014: Ebola outbreak in western Africa declared a public health emergency of international concern by WHO Director‐General • WHO recommendations to: – states with Ebola transmission – states with a potential or confirmed Ebola case, and unaffected states with land borders with affected states – all states
  • 7. WHO recommendations to all states • No general ban on international travel or trade • States should be prepared to detect, investigate, and manage Ebola cases • Exit screening recommended • No postponements of mass gatherings or banning of participants from affected countries • States should be prepared to facilitate the evacuation and repatriation of their nationals who have been exposed to Ebola • States should provide travelers to Ebola-affected and at-risk areas, and the general public with relevant information
  • 8. Beyond a public health emergency United Nations Mission for Ebola Emergency Response (UNMEER) • 18 September 2014: Security Council Resolution 2177 • First‐ever UN emergency health mission; headquarters in Accra, Ghana • Objective: work with others to stop the Ebola outbreak • Strategic guidance: Secretary‐General's Special Envoy, David Nabarro • Operational direction: Secretary‐General's Special Representative, Anthony Banbury • Overall health strategy: WHO • Other UN agencies will act in their areas of expertise
  • 9. Vaccine and treatment development • 2 potential vaccines in pre-clinical trials and 5 candidate vaccines under initial consideration • Extraordinary fast-track procedures coordinated by WHO • Clinical trials expected to start by January 2015 • Scale-up of vaccine stocks by June 2015 latest • Several potential treatments considered, including blood products from survivors
  • 10. The risk to Europe • The risk of Ebola spreading in Europe is very low. • Sporadic imported cases in Europe and accidental contamination remain possible. • European countries have robust health systems and are well prepared to respond to Ebola. • There is low risk tolerance in Europe.
  • 11. Elements of strong health systems • Strong surveillance systems • Laboratory capacity • Case management • Well equipped hospitals with isolation wards • Trained doctors and nurses • Strict adherence to IPC measures • Arrangements for tracing and following contacts • Risk communication
  • 12. Ebola and international travel • WHO recommends exit screening in affected countries of departing travelers • Countries that decide to do entry screening need to ensure it does not interfere with travel and trade, and should share experience. • The main issue is to provide travelers with good information.
  • 13. Medical evacuation “Countries should be prepared to facilitate the evacuation and repatriation of [their] nationals exposed to Ebola”. – IHR emergency committee • Medical evacuation ensures that international workers are available to help. • WHO coordinates medical evacuation for Ebola-infected international workers. • Treatment facilities are being established in western Africa for international responders.
  • 14. WHO overall support in Europe • Early detection, risk assessment and investigation • Overall policy guidance • Support on capacity assessment and scaling up • Technical assistance on strengthening preparedness • Coordination with the European Union and UN • Support to global efforts (staff deployment and advocacy)
  • 15. Real fight is not in Europe • The most effective way to prevent Ebola infections in Europe is to control the epidemic in western Africa. • This requires a fast and strong response. • The international community is scaling up its support. For further information, visit the WHO/Europe website (www.euro.who.int/en/ebola)